News
Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second-quarter ...
Meanwhile, mRNA vaccine maker Moderna is cutting around 500 jobs (10% of its workforce) as part of a commitment to save $1.5 ...
Merck pulled off its $10 billion buyout of Verona Pharma last month with little of the wheeling and dealing that typically ...
Germany's Merck KGaA on Thursday raised its full-year operating earnings guidance, excluding the effect of harsh foreign ...
Drug maker Merck announced Tuesday it will embark on an initiative to cut $3 billion in costs 2027, including an undisclosed ...
Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently talked about. Cramer mentioned the stock and said that ...
Merck will reduce its workforce by approximately 6,000 employees in “some areas of our global workforce,” the New Jersey ...
The stock's rise snapped a four-day losing streak.
Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by ...
Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...
Merck & Co said on Tuesday it was extending its hold on Gardasil shipments to China until at least the end of 2025 due to ...
Merck aims to boost its business by buying Verona Pharma for $10 billion. Through the deal, it will add Ohtuvayre -- a treatment for COPD -- to its portfolio. One of the biggest concerns with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results